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Abstract
Background: Recent studies have suggested that diabetes mellitus (DM) may cause left ventricular
(LV) dysfunction directly resulting in increased susceptibility to heart failure. Using pinhole
collimators and advances in data processing, gated SPECT was recently adapted to image the rat
heart. The present study was aimed to assess this new imaging technique for quantifying LV function
and remodeling from the Streptozotocin (STZ) rat model compared to controls.
Methods: Twenty one rats were randomly assigned to control or diabetic group. Six months after
the induction of diabetes by STZ, Pinhole 99 m Tc-sestamibi gated SPECT was performed for
determining rat LV volumes and function. Post-mortem histopathologic analysis was performed to
evaluate the determinant of LV remodeling in this model.
Results: After six months, the normalized to body weight LV End-systolic volume was significantly
different in diabetic rats compared to controls (0.46 ± 0.02 vs 0.33 ± 0.03 μL/g; p = 0.01). The
normalized LV End-diastolic volume was also different in both groups (1.51 ± 0.03 vs 0.88 ± 0.05
μL/g; p = 0.001) and the normalized stroke volume was significantly higher in STZ-rats (1.05 ± 0.02
vs 0.54 ± 0.06 μL/g; p = 0.001). The muscular fibers were thinner at histology in the diabetic rats
(0.44 ± 0.07 vs 0.32 ± 0.06 AU; p = 0.01).
Conclusion: Pinhole 99 m Tc-sestamibi gated SPECT can successfully be applied for the evaluation
of cardiac function and remodeling in STZ-induced diabetic rats. In this model, LV volumes were
significantly changed compared to a control population, leading to a LV dysfunction. These findings
were consistent with the histopathological abnormalities. Finally, these data further suggest the
presence of diabetes cardiomyopathy.
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Background
Diabetic cardiomyopathy is known to develop in humans
in the absence of coronary or hypertensive disease [1]. The
mechanism by which diabetic cardiomyopathy develops
has been studied in literature using in-vivo and ex-vivo
experiments [2]. It has been postulated that endothelial
dysfunction, endomyocardial fibrosis, direct toxic effect of
hyperglycemia on cardiomyocytes and autonomic neu-
ropathy play an important role. These cardiovascular
complications compromise cardiac performance ulti-
mately resulting in cardiac failure. A high prevalence of
cardiac failure is seen in individuals with diabetic cardio-
vascular complications, with diabetic cardiomyopathy as
one of the key determinants [3].
Because of its accurate reflection of human pathophysiol-
ogy [4], the rat model has also been widely used to study
LV remodeling. Recently, it has been reported that if the
diabetes persists for a long enough time, it induces cardi-
omyopathy, manifesting decreased resting LV ejection
fraction (LVEF) [5,6]. Different imaging modalities have
been used to asses the onset and time course of LV func-
tion abnormalities in small animals with Streptozotocin
(STZ) induced diabetes, especially in rats [7-13]. With the
use of pinhole collimators and the advance in data
processing, gated SPECT was recently adapted to image
the rat heart [14]. The present study was aimed to assess
this new imaging technique for quantifying LV function
and remodeling from the STZ rat model compared to con-
trols. In addition post-mortem histopathologic analysis
was performed to evaluate the determinant of LV remod-
eling in this model.
Methods
Animals handling and study protocol
A total of 21 adult male Wistar Unilever rats (Harlan, The
Netherlands) (11 weeks-old, 345 ± 62 g) were studied.
Diabetes mellitus was induced in 12 rats by a single intra-
venous injection of 45 mg/kg STZ in a 0.1 M citrate buffer
solution. Three days after treatment with STZ, tail vein
blood glucose samples were measured with OnetouchR
glucometer (Johnson & Johnson) to ensure induction of
diabetes (glycemia > 200 mg/dL). In order to study the
diabetic animals over a longer period, a half subcutaneous
implant of insulin (2 U/24 h, Linplant®, Canada) was
inserted at 2 and 4 months.
During all the study the animals were housed in stainless
steel cages with sawdust bedding. They were kept at an
average room temperature of 24°C, a relative humidity of
50% and a 12-hour day/night cycle. All rats had unlimited
access to food and water during follow up.
This study was approved by the Animal Research Commit-
tee at the Vrije Universiteit Brussel and conformed to the
American Heart Association Guidelines for use in animal
research.
Pinhole Gated SPECT Acquisitions
The animals were sedated by intraperitoneal injection of
60 mg/kg of sodium pentobarbital, and 99mTc-sestamibi
(400–700 MBq in a 0.3- to 0.5-mL volume) was injected
intravenously 40–60 min before starting gated SPECT
acquisition. During the acquisition, the animals were in
prone position and were connected to a standard electro-
cardiogram monitor by 3 electrodes placed on the inner
surfaces of limb extremities.
As previously described [14], pinhole gated SPECT acqui-
sitions were performed using a dual head γ-camera
(e.cam™ Signature series Fixed 180; Siemens Medical
Solutions inc.) equipped with a 3-mm pinhole collimator
(195-mm focal length; 43-mm radius of rotation). A
number of 128 projections of 30 seconds per step were
acquired on a 360° rotation and with 16 frames per car-
diac cycle. Additional acquisition parameters were as fol-
lows: 64 × 64 matrix, 2.0 zoom, 126- to 154-keV energy
window, beat acceptance window set to ± 20% of aver-
aged R-R interval. Total acquisition time was 21 min.
Reconstruction and analysis of Pinhole Gated SPECT 
images
As already described [14-16], projection data were cor-
rected for the pinhole geometry, the mechanical shift of
the camera-head rotation and for the nonuniform sensi-
tivity of pinhole detection. Images were thereafter recon-
structed using an ordered-subset expectation
maximization (OSEM) iterative process (2 iterations and
8 subsets), developed in our institution. In addition, a
temporal Fourier filtering was incorporated after each iter-
ation to reduce image noise [14-16]. Voxel size of the
reconstructed images was 0.6 mm and the spatial resolu-
tion was 3 mm in the central slice when determined by the
full width at half maximum on a point source of 99mTc.
Using the 4DMSPECT software (University of Michigan),
myocardial perfusion polar maps were generated from the
reconstructed short axis slices and used to quantify the
extent of perfusion defects defined as the area below 2SD
of a normal database obtained in 20 age matched normal
rats. LVend-diastolic volume (EDV) and end-systolic vol-
ume (ESV), as well as LV ejection fraction (EF), were deter-
mined by QGS software (Cedars Sinai Medical Center, Los
Angeles, USA) [17,18] on contiguous gated short-axis
slices. Constraint limits of contour detection were applied
only in case of evident errors with the fully automatic
process. An example of Pinhole 99 m Tc-sesta mibi gated
SPECT is presented in figure 1. The accuracy of LV vol-Cardiovascular Diabetology 2007, 6:30 http://www.cardiab.com/content/6/1/30
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umes measured with Pinhole gated SPECT was previously
validated with LV rat phantoms [19].
Histology
At the end of follow-up, all rats were euthanized with high
dose pentobarbital. The hearts were immediately
removed and fixed in 4% neutral formalin for 2 hours.
Three short-axis slices of myocardial tissue were obtained
and embedded in paraffin. Heamatoxylin-eosin and Mas-
son's trichrome staining were performed. Microscopy was
done at 400× enlargement. Morphometry was performed
by digital image analysis using a PC digital image camera
(Digital Sight DS-5M, Nikon Corp, Japan) mounted on an
Axiolab Zeiss light microscope (Carl Zeiss Corp, Ger-
many) with a 10× objective (Acroplan, Zeiss). We used the
NIH Image program (Image-J 1.35d, Nation Institutes of
Health, Bethesda, USA). The program was calibrated with
a graduated slide. Microscopic images were used to evalu-
ate blindly the cardiomyocytes. The thickness of the mus-
cular fibers was measured in every sample (10
measurements per sample). Color segmentation was
applied to calculate the percentage of interstitial fibrosis.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). Wilcoxon matched pairs test was used for paired
series and Mann Whitney test was used for two-group
unpaired comparisons. A value of p <0.05 was considered
statistically significant.
Results
Clinical parameters
Glucometry and gravimetry parameters are summarized
in Table 1. After six months, animals treated with STZ
resulted in high glucose levels despite the administration
of subcutaneous implant of insulin, when compared to
controls animals (422 ± 52 vs 99 ± 12 mg/dl, p < 0.001).
Other symptoms frequently associated with diabetic state
such as lower body weights (399 ± 35 vs 658 ± 45 g; p <
0.0001), polyuria, polyphagia were observed in the dia-
betic rats. The heart mass decreased in the diabetic group
but it was not significant compared to controls (1190 ±
280 vs 1370 ± 210 mg; p = 0.6). The heart/body weight
ratio significantly increased in the diabetic group (2.9 ±
0.3 vs 2.2 ± 0.1 mg/g; p = 0.03). At the end of follow up
there was a significant change in heart rate in the diabetic
when compared to control rats (274 ± 9 versus 319 ± 11
bpm; p = 0.01).
Pinhole Gated SPECT measurements
After six months, derived from the pinhole Gated SPECT
measurements, the normalized LVESV was significantly
different in diabetic rats compared to controls (0.46 ±
0.02 vs 0.33 ± 0.03 μL/g; p = 0.01). The normalized
LVEDV was also different in both groups (1.51 ± 0.03 vs
0.88 ± 0.05 μL/g; p = 0.001) and the normalized stroke
volume was significantly higher in STZ-rats (1.05 ± 0.02 vs
Table 1: Glucometry and gravimetry data obtained at 20 weeks of diabetes
Glycemia (mg/dL) Body mass (g) Heart mass (mg) Heart to Body Mass ratio (mg/g)
Controls (n = 9) 99 ± 12 658 ± 45 1370 ± 210 2.2 ± 0.1
Diabetics (n = 12) 422 ± 52* 399 ± 35* 1190 ± 280 2.9 ± 0.3*
*p < 0.05
Example of pinhole SPECT images obtained in one diabetic  rat from long-axis and short-axis slices in systole on the left  and in diastole on the right Figure 1
Example of pinhole SPECT images obtained in one diabetic 
rat from long-axis and short-axis slices in systole on the left 
and in diastole on the right.Cardiovascular Diabetology 2007, 6:30 http://www.cardiab.com/content/6/1/30
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0.54 ± 0.06 μL/g; p = 0.001). These results are summarized
in Table 2.
The mean LVES (0.19 ± 0.01 vs 0.22 ± 0.02 ml; p = 0.117),
LVED (0.59 ± 0.02 vs 0.58 ± 0.033 ml; p = 0.85) and SV
(0.40 ± 0.01 vs 0.36 ± 0.02 ml; p = 0.2) were not signifi-
cantly different between diabetic and control rats. The car-
diac output (CO) was also not different in the diabetic
and control groups (112.0 ± 5.62 vs 113.8 ± 5.49 ml/min;
p = 1). Finally, there was no significant difference in per-
fusion scores between the two groups.
Histology
As shown in the figure 2, the muscular fibers were thinner
in the diabetic rats (0.44 ± 0.07 vs 0.32 ± 0.06 AU; p =
0.01). However, there was no difference for interstitial
fibrosis, first subjectively evaluated, in both groups.
Therefore, color segmentation was applied to calculate the
percentage of interstitial fibrosis. Percentage of fibrosis
was less than 1% in both groups, with no difference
between the two groups at the end of the follow up.
Discussion
The study of cardiomyopathies in small animals may con-
tribute to our understanding of the cardiac pathophysiol-
ogy and to evaluate experimental treatment strategies.
Therefore, this study was aimed to assess the role of Pin-
hole Gated SPECT for quantifying LV function and
remodeling from the STZ rat model compared to controls.
To the best of our knowledge, the present study is the first
to show that this technique can successfully be applied for
the non-invasive evaluation of cardiac function and
remodeling in STZ-induced diabetic rats. Our results indi-
cate that a significant increase in normalized EDV, ESV
and SV had occurred after 6 months follow-up in STZ-
induced diabetic group compared to normal group. Our
data further indicate that these findings were consistent
with the histological changes.
The STZ induced diabetic rats used in our experiments are
reminiscent of a model of uncontrolled hyperglycemia
due to the direct pancreatic beta cell destruction, and
resulting insulin deficiency [20]. Our glucometry and
gravimetry values (Table 1) are in accord with other pub-
lished values at similar time points [21-23]. The signifi-
cant differences in LV mass to body weight ratio between
control and diabetic rats can be explained partly by the
weight loss in the diabetic animals but we cannot exclude
the presence of left ventricular hypertrophy. These rats
with high dose of STZ resembled more like type 1 diabe-
tes. Most of the previous small animals studies have used
M-Mode echocardiography to document LV dysfunction
and remodeling [5,6]. Despite its high temporal resolu-
tion, M-Mode analysis has many limitations and depends
on a lot of geometrical assumptions. Probe alignment is a
particularly important consideration for M-mode
echocardiography, as the perpendicularity of the short
axis plane with the ventricular walls is essential to validate
the mathematical assumptions and equations used to
derive fractional shortening, cardiac dimensions and LV
mass parameters. Therefore, more reliable techniques are
required. With the use of pinhole collimators and the
advance in data processing, gated SPECT was recently
adapted to image the rat heart [14]. This new technique
allows the three-dimensional assessment of the full vol-
umes of the heart, even in rodents. Pinhole 99 m Tc-sesta
mibi gated SPECT has already been applied in the rat inf-
arct model [24,25] and our pinhole gated SPECT tech-
nique was previously shown to provide precise and
reproducible determinations of LV volume and LV func-
tion in normal adult rats[14]. The accuracy of LV volume
measurements using cardiac phantoms has also been doc-
umented previously[19]. More recently, magnetic reso-
nance imaging has been applied successfully in diabetic
rats to evaluate the cardiac structures and function[12,13].
Although these studies have shown similar findings, the
authors acknowledged that the LV planimetry was accom-
plished manually, limiting quantitative accuracy of this
technique. Moreover, the use of 99 m Tc-sesta mibi gated
SPECT reflects more the daily practice because of its broad
availability.
There remains controversy regarding diabetes-induced LV
dysfunction, especially in type 1 diabetes, in the absence
of documented coronary artery disease. Some authors
have been able to detect early systolic LV dysfunction en
dilatation of the left ventricle in STZ induced diabetic car-
diomyopathy [7-11]. On the contrary, others were not
able to demonstrate a remodeling and a significant altera-
tion of the systolic function in a similar rat population
[26].
Table 2: Left ventricular characteristics normalized to body mass
Controls Diabetics
End-Systolic Volume (μL/g) 0.33 ± 0.03 0.46 ± 0.02*
End-Diastolic Volume (μL/g) 0.88 ± 0.05 1.51 ± 0.03*
Stroke Volume (μL/g) 0.54 ± 0.06 1.05 ± 0.02*
* p < 0.05Cardiovascular Diabetology 2007, 6:30 http://www.cardiab.com/content/6/1/30
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We observed an increase in mean normalized EDV of the
diabetic group compared to controls. Meanwhile the nor-
malized ESV of the diabetic rats also increased compared
to controls but in lower proportion. As a consequence, the
stroke volume increased in the diabetic group compared
to controls. The significant increase of normalized EDV
with diabetes in this study is in accordance with previous
reports [5,23,27,28]. However, in contrast to our finding,
other authors have shown no significant change or even
an decrease in this parameter[12,29,30]. We also observed
an increase in normalized ESV, suggesting a decrease in
contractility, in accord with all previous studies
[5,23,27,29,30]. The increase of the SV in diabetic rats was
also shown by Bollano [27] when other authors suggested
a decrease in SV[5,29,30]. This difference in SV could be
explained by the significant bradycardia, that we and Bol-
lano observed in the diabetic group. This was probably a
compensatory mechanism to maintain cardiac output.
The lower heart rate could be related to a longer exposure
to hyperglycaemia. The diabetes duration, that may mod-
ify the time course of LV dysfunction in diabetic rats
[5,23,31], was longer in our study (>20 weeks compared
to 8–12 weeks in previous studies). The differences in LV
volumes may be due to the method used to normalize the
data or to the absence of normalization to body weight in
other studies. Allometric relations exist between cardiac
and body size measurements. However, the correct
method to use in rat is unknown. We normalized LV mass
to bodyweight as applied in the previous studies using the
same animal model [23,28]. In addition, these differences
may reflect the difference in the strain of rats (Wistar Uni-
lever, Wistar Kyoto, Sprague-Dawley), since this factor has
been shown to clearly influence cardiomyopathy in the
STZ model of diabetes [32].
The presence of insulin implants (to permit a longer sur-
vival) had no impact on glucometry, gravimetric values
and cardiac function. As shown by Litwin and colleagues,
an insulin-therapy that aim to normalize the glycemia,
also correct the cardiac abnormalities [31]. Finally, the
dose of STZ injected (45 mg/kg) was low in this study.
However, the impact on glucometry and gravimetric val-
ues was similar compared to the administration of higher
dose of STZ, leading to equivalent absolute insulin defi-
ciency.
In the present study, the muscular fibers were significantly
thinner in the diabetic rats. This last finding was also con-
sistent with previously published work [30]. These mor-
phological changes may partially be responsible for the
changes observed in LV remodeling observed in our study
and the decrease in LV contractility. Nemoto et al have
shown that a long-lasting diabetic state itself, but not the
reduction of heart or body size, induces cardiomyocyte
diameter reduction. The mechanism of the cellular
remodeling of diabetic rats, that is, reduction of transverse
diameter in cardiomyocytes remains unknown. These
authors have suggested that insulin deficiency, which
decreases protein synthesis and promotes protein degra-
dation defective mitochondrial function or altered lyso-
somal enzyme activity might reduce the quantity of actin,
resulting in cellular remodeling [30]. However, no other
significant pathological changes were observed in our dia-
betic rats at the end of the follow up, especially the pres-
ence of fibrosis.
Limitations
Our high dose STZ model resembled more like type 1 dia-
betes and therefore, our results may not be applied to
other forms of diabetes. We did not study the right ventri-
cle or the diastolic function. Finally, we did not use ino-
Histology of normal (a) and diabetic (b) myocardium (Heam- atoxilin-eosin staining, 400×) Figure 2
Histology of normal (a) and diabetic (b) myocardium (Heam-
atoxilin-eosin staining, 400×). The muscle fibers are thinner 
in the diabetic rats. Scale bar is 10 μm.
A
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tropic stimulation in order to unmask a decrease in the
contractile reserve of the left ventricle.
Conclusion
Pinhole 99 m Tc-sestamibi gated SPECT can successfully
be applied for the non-invasive evaluation of cardiac func-
tion and remodeling in STZ-induced diabetic rats. In this
model of diabetic rats, normalized LV volumes were sig-
nificantly changed compared to a control population,
leading to a LV dysfunction. This finding was consistent
with the histopathological abnormalities. Finally, these
data further suggest the presence of diabetes cardiomyop-
athy.
Competing interests
The author(s) declare that they have no competing inter-
ests.
References
1. Marwick TH: Diabetic heart disease.  Heart 2006, 92(3):296-300.
2. Fang ZY, Prins JB, Marwick TH: Diabetic Cardiomyopathy: Evi-
dence, Mechanisms, and Therapeutic Implications.  Endocr Rev
2004, 25(4):543-567.
3. Tziakas DN, Chalikias GK, Kaski JC: Epidemiology of the diabetic
heart.  Coron Artery Dis 2005, 16 Suppl 1:S3-S10.
4. Goldman S, Raya TE: Rat infarct model of myocardial infarction
and heart failure.  J Card Fail 1995, 1(2):169-177.
5. Akula A, Kota MK, Gopisetty SG, Chitrapu RV, Kalagara M, Kalagara
S, Veeravalli KK, Gomedhikam JP: Biochemical, histological and
echocardiographic changes during experimental cardiomy-
opathy in STZ-induced diabetic rats.  Pharmacol Res 2003,
48(5):429-435.
6. Mihm MJ, Seifert JL, Coyle CM, Bauer JA: Diabetes related cardi-
omyopathy time dependent echocardiographic evaluation in
an experimental rat model.  Life Sci 2001, 69(5):527-542.
7. Akula A, Kota M.K, Gopisetty SG, Chitrapu RV, Kalagara M, Kalagara
S, Veeravalli KK, JP. G: Biochemical, histological and echocardi-
ographic changes during experimental cardiomyopathy in
STZ-induced diabetic rats.  Pharmacol Res 2003, 48(5):429-435.
8. Hoit BD, Castro C, Bultron G, Knight S, Matlib MA: Noninvasive
evaluation of cardiac dysfunction by echocardiography in
streptozotocin-induced diabetic rats.  J Card Fail 1999,
5(4):324-333.
9. Joffe II, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan
JP, PS. D: Abnormal cardiac function in the streptozotocin-
induced non-insulin-dependent diabetic rat: noninvasive
assessment with doppler echocardiography and contribution
of the nitric oxide pathway.  J Am Coll Cardiol 1999,
34(7):2111-2119.
10. Mihm MJ, Seifert JL, Coyle CM, Bauer JA: Diabetes related cardi-
omyopathy time dependent echocardiographic evaluation in
an experimental rat model.  Life Sci 2001, 69(5):527-542.
11. Nemoto O, Kawaguchi M, Yaoita H, Miyake K, Maehara K, Maruyama
Y: Left ventricular dysfunction and remodeling in streptozo-
tocin-induced diabetic rats.  Circ J 2006, 70(3):327-334.
12. Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang
CL:  Magnetic resonance imaging analysis of cardiac cycle
events in diabetic rats: the effect of angiotensin-converting
enzyme inhibition.  J Physiol 2002, 538(Pt 2):555-572.
13. Loganathan R, Bilgen M, Al-Hafez B, Smirnova IV: Characterization
of alterations in diabetic myocardial tissue using high resolu-
tion MRI.  Int J Cardiovasc Imaging 2006, 22(1):81-90.
14. Vanhove C, Lahoutte T, Defrise M, Bossuyt A, Franken PR: Repro-
ducibility of left ventricular volume and ejection fraction
measurements in rat using pinhole gated SPECT.  Eur J Nucl
Med Mol Imaging 2005, 32(2):211-220.
15. Vanhove C, Defrise M, Franken PR, Everaert H, Deconinck F, Bossuyt
A: Interest of the ordered subsets expectation maximization
(OS-EM) algorithm in pinhole single-photon emission tom-
ography reconstruction: a phantom study.  Eur J Nucl Med 2000,
27(2):140-146.
16. Vanhove C, Franken PR, Defrise M, Deconinck F, Bossuyt A: Recon-
struction of gated myocardial perfusion SPET incorporating
temporal information during iterative reconstruction.  Eur J
Nucl Med Mol Imaging 2002, 29(4):465-472.
17. Germano G, Kavanagh PB, Berman DS: An automatic approach to
the analysis, quantitation and review of perfusion and func-
tion from myocardial perfusion SPECT images.  Int J Card Imag-
ing 1997, 13(4):337-346.
18. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van
Train KF, Berman DS: Automatic quantification of ejection
fraction from gated myocardial perfusion SPECT.  J Nucl Med
1995, 36(11):2138-2147.
19. Maskali F, Franken PR, Poussier S, Tran N, Vanhove C, Boutley H, Le
Gall H, Karcher G, Zannad F, Lacolley P, Marie PY: Initial Infarct
Size Predicts Subsequent Cardiac Remodeling in the Rat Inf-
arct Model: An In Vivo Serial Pinhole Gated SPECT Study.  J
Nucl Med 2006, 47(2):337-344.
20. Shafrir E: Diabetes in animals: Contribution to the under-
standing of diabetes by study of its etiopathology in animal
models in D. Porte, R.S. Sherwin and A. Baron,Diabetes mel-
litus.  In Diabetes mellitus Edited by: D. Porte RSSAB. NewYork ,
McGraw-Hill; 2003:231–255. 
21. Li XS, Tanz RD, Chang KS: Effect of age and methacholine on
the rate and coronary flow of isolated hearts of diabetic rats.
Br J Pharmacol 1989, 97(4):1209-1217.
22. Nicholl TA, Lopaschuk GD, McNeill JH: Effects of free fatty acids
and dichloroacetate on isolated working diabetic rat heart.
Am J Physiol 1991, 261(4 Pt 2):H1053-9.
23. Hoit BD, Castro C, Bultron G, Knight S, Matlib MA: Noninvasive
evaluation of cardiac dysfunction by echocardiography in
streptozotocin-induced diabetic rats.  J Card Fail 1999,
5(4):324-333.
24. Liu Z, Barrett HH, Stevenson GD, Kastis GA, Bettan M, Furenlid LR,
Wilson DW, Pak KY: High-resolution imaging with (99m)Tc-
glucarate for assessing myocardial injury in rat heart models
exposed to different durations of ischemia with reperfusion.
J Nucl Med 2004, 45(7):1251-1259.
25. Liu Z, Kastis GA, Stevenson GD, Barrett HH, Furenlid LR, Kupinski
MA, Patton DD, Wilson DW: Quantitative analysis of acute
myocardial infarct in rat hearts with ischemia-reperfusion
using a high-resolution stationary SPECT system.  J Nucl Med
2002, 43(7):933-939.
26. Irlbeck M, Zimmer HG: Functional responses of the left and
right heart of diabetic rats to alpha- and beta-adrenergic
receptor stimulation.  Diabetes Res Clin Pract 1996, 31
Suppl:S79-86.
27. Bollano E, Omerovic E, Svensson H, Waagstein F, Fu M: Cardiac
remodeling rather than disturbed myocardial energy metab-
olism is associated with cardiac dysfunction in diabetic rats.
Int J Cardiol 2006, :-. [Epub ahead of print]
28. Joffe, Travers KE, Perreault-Micale CL, Hampton T, Katz SE, Morgan
JP, Douglas PS: Abnormal cardiac function in the streptozo-
tocin-induced non-insulin-dependent diabetic rat: noninva-
sive assessment with doppler echocardiography and
contribution of the nitric oxide pathway.  J Am Coll Cardiol 1999,
34(7):2111-2119.
29. Loganathan R, Bilgen M, Al-Hafez B, Alenezy MD, Smirnova IV: Car-
diac dysfunction in the diabetic rat: quantitative evaluation
using high resolution magnetic resonance imaging.  Cardiovasc
Diabetol 2006, 5:7.
30. Nemoto O, Kawaguchi M, Yaoita H, Miyake K, Maehara K, Maruyama
Y: Left ventricular dysfunction and remodeling in streptozo-
tocin-induced diabetic rats.  Circ J 2006, 70(3):327-334.
31. Litwin SE, Raya TE, Anderson PG, Daugherty S, Goldman S: Abnor-
mal cardiac function in the streptozotocin-diabetic rat.
Changes in active and passive properties of the left ventricle.
J Clin Invest 1990, 86(2):481-488.
32. Rodrigues B, Cam MC, Kong J, Goyal RK, McNeill JH: Strain differ-
ences in susceptibility to streptozotocin-induced diabetes:
effects on hypertriglyceridemia and cardiomyopathy.  Cardio-
vasc Res 1997, 34(1):199-205.